← All organizations
Highest phase reached
Phase 4
First clinical trial
Apr 1, 2013Last known activity
Mar 15, 2022
Timeline
No events for the selected filters.
Drugs by trial phase (5 distinct, 5 trials)
Phase 4 (1 own, 0 via acquisition)
Phase 3 (1 own, 0 via acquisition)
Phase 2 (3 own, 0 via acquisition)
Indications
Recent trials (9)
- NCT05219604Lead sponsorPhase 4Mar 15, 2022
- NCT05420350Lead sponsorPhase 2Dec 16, 2020
- NCT05420350Reponsible party - principal investigatorPhase 2Dec 16, 2020
- NCT05420350Sponsor investigatorPhase 2Dec 16, 2020
- NCT02158585Reponsible party - principal investigatorPhase 3Jun 1, 2014
- NCT02158585Lead sponsorPhase 3Jun 1, 2014
- NCT02008123Lead sponsorPhase 2Aug 1, 2013
- NCT01813591Reponsible party - principal investigatorPhase 2Apr 1, 2013
- NCT01813591Lead sponsorPhase 2Apr 1, 2013
Details
- Last known activity
- Mar 15, 2022